Aloxi

Active Ingredient(s): Palonosetron
FDA Approved: * July 25, 2003
Pharm Company: * HELSINN HLTHCARE
Category: Cancer

Palonosetron, sold under the brand name Aloxi, is used for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).[1][3][4] It is a 5-HT3 antagonist.[1][3][4] Palonosetron is administered intravenously,[5] or as a single oral capsule.[6] It has a longer duration of action than other 5-HT3 antagonists. The oral formulation was approved on Aug... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Aloxi .25 mg/5ml Intravenous Injection

NDC: 62856-797

Labeler:

Eisai, Inc

Aloxi .075 mg/1.5ml Intravenous Injection

NDC: 62856-798

Labeler:

Eisai, Inc

Aloxi 0.5 mg (Palonosetron Hydrochloride 0.056 mg) Oral Capsule

NDC: 62856-799

Labeler:

Eisai

Aloxi .05 mg/ml Intravenous Injection

NDC: 69639-103

Labeler:

Helsinn Therapeutics (U.s.), Inc.

Aloxi .5 mg/.5mg Oral Capsule

NDC: 69639-104

Labeler:

Helsinn Therapeutics (U.s.), Inc.